One previous study of 115 cervical cancer samples from Norway and Mexico identified previously unknown somatic mutations that recurrently occurred in EP300, FBXW7, NFE2L2, TP53, and ERBB2 [11]. This evidence concerns the gene NFE2L2 and cervical carcinoma.